Tomoko IIda
      OUR PEOPLE

      Tomoko Iida

      MEng in Biomedical Engineering, MBA 

      Director Scientific Engagement SSEA, CIS & MEA Region 

      Contact

      Tomoko is Director Scientific Engagement SSEA, CIS & MEA Region*, where she is responsible for the scientific engagement activities focusing on increasing awareness and understanding within the scientific community about the science behind tobacco harm reduction and the smoke-free product category. Prior to expanding the geographical coverage, she was Director Scientific Engagement Asia Region (EA&A and SSEA) for 3 years. She is a talented public speaker who also uses her platform to promote Asian leadership as well as Women in STEM.

      Before moving to a regional role from Tokyo, she took an active role in overseeing the introduction of our Tobacco Heating System in Japan.

      Japanese by origin, Tomoko holds a MEng in Biomedical Engineering and a BSc in Chemical Engineering from MIT (Massachusetts Institute of Technology) and an MBA from Imperial College London. She is currently working toward a DrPH (Doctor of Public Health) degree. She worked at MIT Biotechnology Process Engineering Center in the USA and Sony Corporation Life Science Laboratory in Japan.

       

      * South and Southeast Asia (SSEA), Commonwealth of Independent States (CIS) & Middle East and Africa (MEA) Region

      Latest Publications

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.